Biogen Idec's Back

On Tuesday, Biogen Idec celebrated the opening of 225 Binney St, the first of two new buildings (totaling nearly 500k SF) that it will occupy in Kendall Square. Binney Street is part of a $500M complex that Alexandria is developing. Boston Properties has another building under construction nearby for the biotech company. In ’11, Biogen Idec had moved many of its people to Weston, leaving others in its original hometown of Cambridge. When George Scangos became CEO several months later, he decided to reunite the company. It will enhance the collaboration needed to make decisions quickly and put Biogen Idec back in the midst of a leading global cluster of life science companies, universities, and big pharma, he says.

Continue reading this story with a free account

Log in or register
Related Topics: Binney Street
Sign up for more articles like this
Subscribe to Bisnow's Boston Newsletters
Related Stories

From Pandemic Darling To Cautionary Tale: Pickleball Clubs Face A Reckoning After Betting Big On Retail Space

'Distress Is Finally Trading': Investors Chasing Big Discounts On Boston Office

140-Acre Attleboro Golf Course Hits Market, Pitched For Redevelopment

'It's A 2-Way Street': Philly Hospital CEOs Seek Cost Savings From Architects, Builders

Foundry Robotics Leaves San Francisco For New East Bay HQ

Alexandria Sells Stakes In Megacampuses To Weather Life Sciences Downturn

Nonprofit Developer Buys Mattapan Site For Affordable Housing: The Boston Deal Sheet

Tenant Rep Firm Expands To Philly, Hires Industry Veteran

Downtown Office Tower Sells At Foreclosure Auction For $260M

Data Centers Lose The Top Spot, San Francisco Jumps 40 Places: 9 Takeaways From ULI's 2027 Outlook

JLL Sues Ex-Life Sciences Leader, Alleging Breach Of Noncompete

Cushman & Wakefield, NYC Added To Suit Alleging $250K Agency Lease Shakedown